Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- XEO-001/07Independent statistical analysis of Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face: primary endpoint results,…
- XEPADIndependent statistical analysis of An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- XERADIndependent statistical analysis of A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- XIENCE 28 Global Study: Complete Statistical AnalysisIndependent statistical analysis of XIENCE 28 Global Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355742).
- XIENCE PRIME Japan Post-Marketing Surveillance (PMS): Complete Statistical AnalysisIndependent statistical analysis of XIENCE PRIME Japan Post-Marketing Surveillance (PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01721096).
- XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS): Complete Statistical AnalysisIndependent statistical analysis of XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- XPAND-IIIndependent statistical analysis of AirXpanders AeroForm Tissue Expander System for Breast Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504424).
- Xplore2Independent statistical analysis of Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03022708).
- Y-ACTIndependent statistical analysis of Yoga in Adult Cancer: A Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02309112).
- YeapleIndependent statistical analysis of Clinical Efficacy of a Toothpaste on Hypersensitivity Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01040169).
- Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): Complete Statistical AnalysisIndependent statistical analysis of Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YELLOWIndependent statistical analysis of Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01567826).
- YELLOW IIIIndependent statistical analysis of Effect of Evolocumab on Coronary Plaque Characteristics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04710368).
- YES-PIndependent statistical analysis of Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- YNQIndependent statistical analysis of Yes/No Questionnaire for Aphasic Patients (YNQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257696).
- Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: Complete Statistical AnalysisIndependent statistical analysis of Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159299).
- Yoga and Female Concussion: Complete Statistical AnalysisIndependent statistical analysis of Yoga and Female Concussion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07170488).
- Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YOSEMITEIndependent statistical analysis of Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma: primary endpoint results,…
- Young Men and Media Study: Complete Statistical AnalysisIndependent statistical analysis of Young Men and Media Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04109443).
- Youth Mayo Clinic Anxiety Coach Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Youth Mayo Clinic Anxiety Coach Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02205177).
- Youth-Led Intervention to Improve Blood Pressure: Complete Statistical AnalysisIndependent statistical analysis of Youth-Led Intervention to Improve Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05029687).
- YPPProConIndependent statistical analysis of Young Parents Program, Project Connect: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01379924).
- ZACFASTIndependent statistical analysis of Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00862836).
- Zaleplon 10mg Capsules Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Zaleplon 10mg Capsules Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00829998).
- ZamCATIndependent statistical analysis of Zambia Chlorhexidine Application Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01241318).
- ZAPSIndependent statistical analysis of Zip Arthroplasty Patient Satisfaction Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03178266).
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin: Complete Statistical AnalysisIndependent statistical analysis of ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ZEALIndependent statistical analysis of Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ZEAL UNLOCKIndependent statistical analysis of A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ZENITHIndependent statistical analysis of A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH): primary endpoint results, effect estimate with confidence interval,…
- ZENITHIndependent statistical analysis of Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Zenith® Low Profile AAA Endovascular Graft: Complete Statistical AnalysisIndependent statistical analysis of Zenith® Low Profile AAA Endovascular Graft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02535065).
- Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Complete Statistical AnalysisIndependent statistical analysis of Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Zero Heat Flux Thermometry System Comparison Trial: Complete Statistical AnalysisIndependent statistical analysis of Zero Heat Flux Thermometry System Comparison Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670760).
- ZESCAIndependent statistical analysis of Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ZEUSIndependent statistical analysis of Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493467).
- Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490723).
- Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1): Complete Statistical AnalysisIndependent statistical analysis of Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Zinc for the Treatment of Herpes Simplex Labialis (HSL): Complete Statistical AnalysisIndependent statistical analysis of Zinc for the Treatment of Herpes Simplex Labialis (HSL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00809809).
- Zip-Stitch™ for Vaginal Cuff Closure in Laparoscopic Hysterectomy – Safety & Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Zip-Stitch™ for Vaginal Cuff Closure in Laparoscopic Hysterectomy - Safety & Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zirconia Based Fixed Dental Prostheses: Complete Statistical AnalysisIndependent statistical analysis of Zirconia Based Fixed Dental Prostheses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02220764).
- ZMUIndependent statistical analysis of Dental Implant Study Comparing Two Types of Metals Used for Dental Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ZODIACIndependent statistical analysis of OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…